ELISA, Western Blotting (WB), Immunocytochemistry (ICC)
Spezifität
INPP4B antibody is human, mouse and rat reactive. At least two isoforms of INPP4B are known to exist, this antibody only detects the longer isoform. INPP4B antibody is predicted to not cross-react with INPP4A.
Aufreinigung
INPP4B antibody is affinity chromatography purified via peptide column.
Immunogen
INPP4B antibody was raised against a 17 amino acid peptide near the amino terminus of human INPP4B. The immunogen is located within the last 50 amino acids of INPP4B.
INPP4B
Reaktivität: Human
ELISA, WB
Wirt: Maus
Monoclonal
unconjugated
Applikationshinweise
INPP4B antibody can be used for detection of INPP4B by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunocytochemistry starting at 2.5 μ,g/mL.
Antibody validated: Western Blot in mouse samples and Immunocytochemistry in mouse samples. All other applications and species not yet tested.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
INPP4B antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C,4 °C
Informationen zur Lagerung
INPP4B antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
INPP4B
(Inositol Polyphosphate-4-Phosphatase, Type II, 105kDa (INPP4B))
E130107I17Rik antikoerper, inositol polyphosphate-4-phosphatase, type II antikoerper, inositol polyphosphate-4-phosphatase type II B antikoerper, Inpp4b antikoerper, INPP4B antikoerper
Hintergrund
Inositol polyphosphate 4-phosphatase type II (INPP4B) is one of the enzymes involved in phosphatidylinositol signaling pathways. It removes the phosphate group at position 4 of the inositol ring from inositol 3,4-bisphosphate (1). INPP4B can function as a tumor suppressor by inhibiting PI3K signaling. In human epithelial cells, knockdown of INPP4B expression resulted in enhanced Akt activation, anchorage-independent growth, and enhanced overall motility (2). It is thought INPP4B may also have oncogenic functions as INPP4B-dependent PI3K signaling is mediated by SGK3 in breast cancer cells and expression of INPP4B leads to enhanced SGK3 activation and suppression of AKT phosphorylation (3).